These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2295944)

  • 1. Nonuniformity of tumor dose in radioimmunotherapy.
    Humm JL; Cobb LM
    J Nucl Med; 1990 Jan; 31(1):75-83. PubMed ID: 2295944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 131I radioimmunotherapy and fractionated external beam radiotherapy: comparative effectiveness in a human tumor xenograft.
    Barendswaard EC; O'Donoghue JA; Larson SM; Tschmelitsch J; Welt S; Finn RD; Humm JL
    J Nucl Med; 1999 Oct; 40(10):1764-8. PubMed ID: 10520720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodies.
    Behr TM; Sharkey RM; Juweid ME; Dunn RM; Ying Z; Zhang CH; Siegel JA; Goldenberg DM
    J Nucl Med; 1997 Mar; 38(3):409-18. PubMed ID: 9074529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody and radionuclide characteristics and the enhancement of the effectiveness of radioimmunotherapy by selective dose delivery to radiosensitive areas of tumour.
    Flynn AA; Pedley RB; Green AJ; Boxer GM; Boden R; Bhatia J; Morris R; Begent RH
    Int J Radiat Biol; 2002 May; 78(5):407-15. PubMed ID: 12020430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics, biodistribution, and dosimetry of specific and control radiolabeled monoclonal antibodies in patients with primary head and neck squamous cell carcinoma.
    Maraveyas A; Stafford N; Rowlinson-Busza G; Stewart JS; Epenetos AA
    Cancer Res; 1995 Mar; 55(5):1060-9. PubMed ID: 7866989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated microscopic-macroscopic pharmacology of monoclonal antibody radioconjugates: the radiation dose distribution.
    Fujimori K; Fisher DR; Weinstein JN
    Cancer Res; 1991 Sep; 51(18):4821-7. PubMed ID: 1893374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of radiation dose to the nucleus by vesicular internalization of iodine-125-labeled A33 monoclonal antibody.
    Daghighian F; Barendswaard E; Welt S; Humm J; Scott A; Willingham MC; McGuffie E; Old LJ; Larson SM
    J Nucl Med; 1996 Jun; 37(6):1052-7. PubMed ID: 8683300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-factor calculations for mouse models using Monte-Carlo simulations.
    Bitar A; Lisbona A; Bardiès M
    Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):343-51. PubMed ID: 17538523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internal dosimetry using data derived from autoradiographs.
    Humm JL; Macklis RM; Bump K; Cobb LM; Chin LM
    J Nucl Med; 1993 Oct; 34(10):1811-7. PubMed ID: 8410302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiolabeled antibody combined with external radiotherapy for the treatment of head and neck cancer: reconstruction of a theoretical phantom of the larynx for radiation dose calculation to local tissues.
    Maraveyas A; Myers M; Stafford N; Rowlinson-Busza G; Stewart JS; Epenetos AA
    Cancer Res; 1995 Mar; 55(5):1020-7. PubMed ID: 7866985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting strategies for cancer radiotherapy.
    Buchsbaum DJ; Rogers BE; Khazaeli MB; Mayo MS; Milenic DE; Kashmiri SV; Anderson CJ; Chappell LL; Brechbiel MW; Curiel DT
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies.
    Wong JYC ; Chu DZ; Yamauchi DM; Williams LE; Liu A; Wilczynski S; Wu AM; Shively JE; Doroshow JH; Raubitschek AA
    Clin Cancer Res; 2000 Oct; 6(10):3855-63. PubMed ID: 11051230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
    Elgqvist J; Andersson H; Bäck T; Hultborn R; Jensen H; Karlsson B; Lindegren S; Palm S; Warnhammar E; Jacobsson L
    J Nucl Med; 2005 Nov; 46(11):1907-15. PubMed ID: 16269606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell cytotoxicity with radiolabeled antibodies.
    Ong GL; Elsamra SE; Goldenberg DM; Mattes MJ
    Clin Cancer Res; 2001 Jan; 7(1):192-201. PubMed ID: 11205908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments.
    Casey JL; Pedley RB; King DJ; Green AJ; Yarranton GT; Begent RH
    Br J Cancer; 1999 Nov; 81(6):972-80. PubMed ID: 10576653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
    Buchsbaum D; Khazaeli MB; Liu T; Bright S; Richardson K; Jones M; Meredith R
    Cancer Res; 1995 Dec; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing the sequence of combination therapy with radiolabeled antibodies and fractionated external beam.
    Ruan S; O'Donoghue JA; Larson SM; Finn RD; Jungbluth A; Welt S; Humm JL
    J Nucl Med; 2000 Nov; 41(11):1905-12. PubMed ID: 11079503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.
    Wong JY; Shibata S; Williams LE; Kwok CS; Liu A; Chu DZ; Yamauchi DM; Wilczynski S; Ikle DN; Wu AM; Yazaki PJ; Shively JE; Doroshow JH; Raubitschek AA
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5842-52. PubMed ID: 14676105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo MCNP-4B-based absorbed dose distribution estimates for patient-specific dosimetry.
    Yoriyaz H; Stabin MG; dos Santos A
    J Nucl Med; 2001 Apr; 42(4):662-9. PubMed ID: 11337557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.